Glaxosmithkline Pharmaceuticals informs about analyst meet

11 Feb 2025 Evaluate
Pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed that an group analyst meeting is scheduled on 14th February 2025 via Digital.

The above information is a part of company’s filings submitted to BSE.


Glaxosmithkline Phar Share Price

2407.55 10.10 (0.42%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.20
Dr. Reddys Lab 1182.75
Cipla 1325.85
Zydus Lifesciences 878.80
Lupin 2138.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×